Rezolute, Inc. (RZLT)
Data as of , from SEC Form 4 filings.
See up to 3 months of RZLT. The 7-day demo opens the 1M and 3M ranges and puts RZLT on your watchlist.
Start 7-day demoLatest RZLT insider trades
About Rezolute, Inc. (RZLT)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
- REDWOOD CITY, CA
- 58
- 2011
- Nasdaq
RZLT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Tax withholding / forfeiture | 1 | 2,267 | |
| Bona-fide gift | 3 | 24,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RZLT insider transactions (Form 4)
3725 Form 4 filings on record, the earliest from Dec 10, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Daron Evans - Officer | Gift | Common Shares | 16,000 footnote F1 | $0.00 | - | |
| Daron Evans - Officer | Gift | Common Shares | 4,000 | $0.00 | - | |
| Daron Evans - Officer | Gift | Common Shares | 4,000 | $0.00 | - | |
| ||||||
| Sunil Ratilal Karnawat - Officer | Tax withholding / forfeiture | Common Shares | 2,267 | $4.50 | $10K | |
| Brian Kenneth Roberts - Officer | Tax withholding / forfeiture | Common Shares | 3,062 | $4.99 | $15K | |
| Nevan C. Elam - Officer | Tax withholding / forfeiture | Common Shares | 8,004 | $4.99 | $40K | |
| Daron Evans - Officer | Tax withholding / forfeiture | Common Shares | 3,062 | $4.99 | $15K | |
| Daron Evans - Officer | Open-market purchase | Common Shares | 10,000 | $2.85 | $29K | |
| Brian Kenneth Roberts - Officer | Tax withholding / forfeiture | Common Shares | 11,439 | $2.99 footnote F2 | $34K | |
| ||||||
| Daron Evans - Officer | Tax withholding / forfeiture | Common Shares | 11,438 | $2.99 footnote F2 | $34K | |
| ||||||
| Nevan C. Elam - Officer | Tax withholding / forfeiture | Common Shares | 27,618 | $2.99 footnote F2 | $83K | |
| ||||||
| Wladimir Hogenhuis | Open-market purchase | Common Shares | 5,650 | $1.69 | $10K | |
| Brian Kenneth Roberts - Officer | Open-market purchase | Common Shares | 28,000 | $1.70 | $48K | |
| Brian Kenneth Roberts - Officer | Grant or award | Common Shares | 123,000 footnote F1 | $0.00 | - | |
| ||||||
| Sunil Ratilal Karnawat - Officer | Grant or award | Common Shares | 32,000 footnote F1 | $0.00 | - | |
| Sunil Ratilal Karnawat - Officer | Grant or award | Employee Stock Option (Right to Buy) | 19,000 | $0.00 | - | |
| ||||||
| Nerissa Kreher | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Nerissa Kreher | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Wladimir Hogenhuis | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Wladimir Hogenhuis | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Erik Harris | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Erik Harris | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Young-Jin Kim | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Young-Jin Kim | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Philippe Fauchet | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Philippe Fauchet | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Daron Evans - Officer | Grant or award | Common Shares | 107,000 footnote F1 | $0.00 | - | |
| Daron Evans - Officer | Grant or award | Employee Stock Option (Right to Buy) | 63,000 | $0.00 | - | |
| ||||||
| Gil M. Labrucherie | Grant or award | Common Shares | 21,000 footnote F1 | $0.00 | - | |
| Gil M. Labrucherie | Grant or award | Director Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| ||||||
| Nevan C. Elam - Officer | Grant or award | Common Shares | 317,000 footnote F1 | $0.00 | - | |
| Nevan C. Elam - Officer | Grant or award | Employee Stock Option (Right to Buy) | 186,000 | $0.00 | - | |
| ||||||
| Sunil Ratilal Karnawat - Officer | Grant or award | Common Shares | 25,000 | $0.00 | - | |
| Sunil Ratilal Karnawat - Officer | Grant or award | Employee Stock Option (Right to Buy) | 275,000 | $0.00 | - | |
| Daron Evans - Officer | Open-market purchase | Common Shares | 10,000 | $4.29 | $43K | |
| Daron Evans - Officer | Open-market purchase | Common Shares | 9,000 | $4.60 | $41K | |
| Daron Evans - Officer | Open-market purchase | Common Shares | 10,549 | $5.04 | $53K | |
Item 7.01, 9.01
Item 7.01, 9.01
Item 7.01, 9.01
Item 2.02, 9.01
RZLT insider trading FAQ
What is the latest insider trade for RZLT?
Rezolute, Inc. (RZLT) had 2 insider filings in the last 90 days, with the most recent on 23 October 2026. The full record for RZLT runs to 25 Form 4 filings, the earliest from 10 December 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RZLT stock?
No insider purchases of RZLT were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling RZLT stock?
No insider sales of RZLT were filed in the last 90 days.
Where can I see RZLT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RZLT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daron Evans view on EDGAR
- - Sunil Ratilal Karnawat view on EDGAR
- - Brian Kenneth Roberts view on EDGAR
- - Nevan C. Elam view on EDGAR
- - Daron Evans view on EDGAR
- - Daron Evans view on EDGAR
- - Brian Kenneth Roberts view on EDGAR
- - Daron Evans view on EDGAR
- - Nevan C. Elam view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where RZLT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RZLT with a 7-day demo
- RZLT on your watchlist
- Every RZLT Form 4 filing on record
- Up to 3 months of RZLT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
